Zhu and colleagues reported that sclerostin was over-expressed in breast cancer tumor tissues and cell lines and that the inhibition of sclerostin by specific antibody significantly reduced migration and invasion of breast cancer cell lines in a time-and dose-dependent manner. The gene discussed is SOST; the disease is breast carcinoma.